Maxwell M. Krem

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis”.

An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis

Bone Marrow Transplantation(2021)10.1038/s41409-021-01450-3

N/A

0.500DataRank · unranked

27 citations

Marcos de Lima, Krishna V. Komanduri, Trent Wang, Mei-Jie Zhang, Karen Chen +56 more

Impact of Pretransplantation Renal Dysfunction on Outcomes after Allogeneic Hematopoietic Cell Transplantation

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.02.030

N/A

0.494DataRank · unranked

26 citations

Ajoy Dias, Tao Wang, Caitrin Fretham, Saurabh Chhabra, Hemant S. Murthy +30 more

Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis

Blood Advances(2023)10.1182/bloodadvances.2023011308

N/A

0.483DataRank · unranked

24 citations

Mei‐Jie Zhang, Karen Chen, Sairah Ahmed, Uday Deotare, Siddhartha Ganguly +64 more

Transplant outcomes using older matched sibling donors compared with young alternative donors: a CIBMTR analysis

Blood Advances(2025)10.1182/bloodadvances.2024014858

N/A

0.464DataRank · unranked

21 citations

Mei‐Jie Zhang, Matthew Bye, Muhammad Bilal Abid, Cara L. Benjamin, B Betts +18 more

Bortezomib-Based Induction Is Associated with Superior Outcomes in Light Chain Amyloidosis Patients Treated with Autologous Hematopoietic Cell Transplantation Regardless of Plasma Cell Burden

Transplantation and Cellular Therapy(2020)10.1016/j.jtct.2020.11.018

N/A

0DataRank · unranked

18 citations

Raphael Fraser, Luciano J. Costa, Stacey Goodman, Noel Estrada‐Merly, Cindy Lee +20 more

Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis

Haematologica(2023)10.3324/haematol.2022.281958

N/A

0DataRank · unranked

33 citations

Soyoung Kim, Noel Estrada‐Merly, Muhammad Bilal Abid, Mahmoud Aljurf, Amer Assal +44 more

Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study

Blood Advances(2024)10.1182/bloodadvances.2024013451

N/A

0DataRank · unranked

14 citations

Noel Estrada‐Merly, María Queralt Salas, Soyoung Kim, Jakob D. DeVos, Min Chen +59 more

Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: a center for international blood and marrow transplant research analysis

UNC Libraries(2024)10.17615/d5s2-9s76

N/A

0DataRank · unranked

0 citations

Peter A. Riedell, R. Alejandro Sica, Tania Jain, Brian T. Hill, Craig S. Sauter +24 more

Noninfectious Pulmonary Toxicity after Allogeneic Hematopoietic Cell Transplantation

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.03.015

N/A

0DataRank · unranked

27 citations

Kwang Woo Ahn, Manoj Khanal, Caitrin Bupp, Mariam Allbee‐Johnson, Navneet S. Majhail +24 more

Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia

Blood Advances(2021)10.1182/bloodadvances.2021004916

N/A

0DataRank · unranked

77 citations

Leland Metheny, Mei‐Jie Zhang, Hailin Wang, Noel Estrada‐Merly, David I. Marks +72 more

Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United States

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.04.013

N/A

0DataRank · unranked

25 citations

Ruta Brazauskas, Rachel B. Salit, Karen L. Syrjala, Stephanie Bo‐Subait, Heather R. Tecca +48 more

Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML

Blood Advances(2021)10.1182/bloodadvances.2021004881

N/A

0DataRank · unranked

13 citations

Alexandra Gomez-Arteaga, Rafael Madero‐Marroquin, Mei‐Jie Zhang, Khalid Bo-Subait, J. Ortiz Sánchez +51 more